CTRI/2009/091/001087Other3 期
AN OPEN LABEL, RANDOMIZED, PARALLEL GROUP, PROSPECTIVE, MULTICENTRE CLINICAL TRIAL FOR EVALUATION OF EFFICACY AND SAFETY OF IN-PHRM-001 IN COMPARISON WITH ALLOPURINOL IN ADULT PATIENTS WITH GOUT
试验速览
- 阶段
- 3 期
- 状态
- Other
- 入组人数
- 270
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •(1) Patients of either sex between 18 and 80 years of age diagnosed with hyperuricemia (Serum uric acid greater or equal to 7 mg/dL) and gout by ARA Criteria
排除标准
- •(1) Impaired hepatic or renal function
- •(2) History of Serious cardiovascular disease
- •(3) Pregnancy or lactation
- •(4) Ongoing therapy with any prohibited medication or allopurinol >300mg/d
- •(5) History of xanthinuria or active liver disease
- •(6) History of alcohol abuse
- •(7) Secondary hyperuricaemic conditions
- •(8) Contraindication to colchicines
- •(9) Participated in another investigational trial within 30 days prior to screening visit
- •(10) History of known hypersensitivity to febuxostat, allopurinol, colchicine or any components in their formulation.
- •(11) History of cancer within 5 years prior to the screening visit, or had taken any systemic cancer chemotherapy within 5 years prior to the screening visit
研究者
相似试验
已完成
3 期
6-WEEK TRIAL OF THE EFFICACY AND SAFETY OF ASENAPINE COMPARED TO RISPERIDONE IN ADULT PATIENT WITH ACUTE EXACERBATION OF SCHIZOPHRENIACTRI/2010/091/000423Intas Pharmaceuticals Limited280
Unknown
3 期
13-WEEK STUDY FOR EVALUATION OF EFFICACY AND SAFETY OF IN-AQUL-002 TABLET COMPARED TO OXCARBAZEPINE SUSTAINED-RELEASE TABLET AS ADJUNCTIVE TREATEMENT IN ADULT PATIENTS WITH REFRACTORY PARTIAL-ONSET SEIZURESCTRI/2010/091/006085Intas Pharmaceuticals Limited270
已完成
3 期
Phase III clinical trial for Evaluation of Efficacy and Safety of IN-PHARM-002 in Comparison with Ibuprofen in adult patients with acute painful soft tissue injury.CTRI/2009/091/001067Intas Pharmaceuticals Limited204
已完成
3 期
CLINICAL TRIAL FOR EVALUATION OF EFFICACY AND SAFETY OF PRASUGREL IN COMPARISON WITH CLOPIDOGREL IN ACUTE CORONARY SYNDROME (ACS) PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI).CTRI/2009/091/001085Intas Pharmaceuticals Limited240
尚未招募
2 期
A clinical study to evaluate effectiveness of Unani formulations in TineaCTRI/2020/04/024765ational Research Institute of Unani Medicine for Skin Disorders